NEWS

Monday, November 20, 2023

The foundations of the ECHoS project are laid and Cancer Mission activities are speeding up in Norway.

Friday, November 10, 2023

Are polygenic risk scores the answer?

Thursday, November 2, 2023

Thomas London has joined the board of Oslo Cancer Cluster Incubator.

Thursday, October 19, 2023

How can manufacturing of T cell therapies be improved?

Wednesday, October 18, 2023

New data shows 27% improved survival in the NIPU trial.

Friday, October 6, 2023

Her er de viktigste sakene i Statsbudsjettet 2024 for Oslo Cancer Clusters medlemmer.

Thursday, September 28, 2023

SurViva is a Norwegian consultancy providing quality guidance for life science companies.

Wednesday, September 6, 2023

New Norwegian research in polygenic risk score

Wednesday, August 23, 2023

What is the government's ambition for the health industry?